Alnylam Pharma (ALNY) Posts Smaller-than-Expected Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Alnylam Pharmaceuticals (ALNY) PT Lowered to $116 at Evercore ISI
May 4, 2018 7:51 AM EDTEvercore ISI lowered its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $116.00 (from $118.00) while maintaining a In Line rating.
... More